|Bid||110.00 x 800|
|Ask||180.44 x 1400|
|Day's range||131.69 - 137.80|
|52-week range||126.94 - 231.00|
|Beta (5Y monthly)||1.48|
|PE ratio (TTM)||27.72|
|Earnings date||25 Apr 2022 - 29 Apr 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||140.00|
Medpace Holdings (NASDAQ:MEDP) has had a rough month with its share price down 11%. However, stock prices are usually...
Illumina's (ILMN) first companion diagnostic claim for TSO Comprehensive (EU) will help identify cancer patients with NTRK gene fusions for a genomically matched treatment.
Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.